Varying strategies among managed care organizations for PCSK9 inhibitors will shape the care of high-risk cardiovascular patients.
Matt Jarvis, PharmD
Advertisement
Articles by Matt Jarvis, PharmD
Advertisement
Latest Updated Articles
PCSK9 Inhibitors: Who are the Best Candidates for Therapy?Published: August 16th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Healthy Gut Could Improve Mental Health
2
FDA Approves First Oral GLP-1 for Weight Management
3
Reimagining Pharmacy: A Call to Action for Pharmacy Professionals
4
FDA Approves Milestone Oral Therapy for Adults With Thalassemia Anemia
5